Intellia Therapeuticsincis A Clinical Stage Genome Editing Company Based In Cambridgemassachusettsfounded In 2014It Focuses On Developing Innovative Therapeutics Using Crispr Gene Editing Technologythe Company Aims To Create Potentially Curative Treatments That Could Significantly Impact The Medical Field The Founding Team Includes Notable Scientists And Entrepreneurssuch As Jennifer Doudna And Nessan Berminghamintellia Has Secured Substantial Funding Through Venture Capitaldemonstrating Strong Investor Confidencethe Company Has Established Key Partnerships With Organizations Like Atlas Venture And Novartis Institutes For Biomedical Researchenhancing Its Position In The Biotech Industry Intellia S Mission Is To Harness Crispr Technology To Develop Groundbreaking Therapiesby Leveraging Scientific Expertise And A Robust Intellectual Property Portfoliothe Company Is Dedicated To Advancing Crispr Based Treatments For Various Diseases
No conferences found for this company.
| Company Name | Intellia Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
